(Q40247703)

English

Pilot study to assess toxicity and pharmacokinetics of docetaxel in patients with metastatic breast cancer and impaired liver function secondary to hepatic metastases

scientific article published on 14 May 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

18 September 2017

Pilot study to assess toxicity and pharmacokinetics of docetaxel in patients with metastatic breast cancer and impaired liver function secondary to hepatic metastases (English)

1 reference

Europe PubMed Central

18 September 2017

metastatic breast cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

Gabriel N Hortobagyi

9

object named as

Gabriel N Hortobagyi

1 reference

Europe PubMed Central

18 September 2017

author name string

Karen Eckmann

1

1 reference

Europe PubMed Central

18 September 2017

Laura B Michaud

2

1 reference

Europe PubMed Central

18 September 2017

Edgardo Rivera

3

1 reference

Europe PubMed Central

18 September 2017

Timothy L Madden

4

1 reference

Europe PubMed Central

18 September 2017

Laura Esparza-Guerra

5

1 reference

Europe PubMed Central

18 September 2017

Jitesh Kawedia

6

1 reference

Europe PubMed Central

18 September 2017

Daniel J Booser

7

1 reference

Europe PubMed Central

18 September 2017

Marjorie C Green

8

1 reference

Europe PubMed Central

18 September 2017

Vicente Valero

10

1 reference

Europe PubMed Central

18 September 2017

publication date

14 May 2013

1 reference

Europe PubMed Central

18 September 2017

Journal of Oncology Pharmacy Practice

1 reference

Europe PubMed Central

18 September 2017

20

1 reference

Europe PubMed Central

18 September 2017

2

1 reference

Europe PubMed Central

18 September 2017

120-129

1 reference

Europe PubMed Central

18 September 2017

Treatment outcome and prognostic factors for patients with bone-only metastases of breast cancer: a single-institution retrospective analysis

1 reference

https://api.crossref.org/works/10.1177%2F1078155213480536

21 January 2018

Clinical course of breast cancer patients with metastases limited to the liver treated with chemotherapy

1 reference

https://api.crossref.org/works/10.1177%2F1078155213480536

21 January 2018

Metastatic breast cancer with liver metastases: a registry analysis of clinicopathologic, management and outcome characteristics of 500 women

1 reference

https://api.crossref.org/works/10.1177%2F1078155213480536

21 January 2018

Paclitaxel and recombinant human granulocyte colony-stimulating factor as initial chemotherapy for metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1177%2F1078155213480536

21 January 2018

Phase II trial of docetaxel: a new, highly effective antineoplastic agent in the management of patients with anthracycline-resistant metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1177%2F1078155213480536

21 January 2018

Docetaxel for treatment of solid tumours: a systematic review of clinical data

1 reference

https://api.crossref.org/works/10.1177%2F1078155213480536

21 January 2018

A phase II study of docetaxel in patients with paclitaxel-resistant metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1177%2F1078155213480536

21 January 2018

Phase I and pharmacokinetic trial of paclitaxel in patients with hepatic dysfunction: Cancer and Leukemia Group B 9264.

1 reference

https://api.crossref.org/works/10.1177%2F1078155213480536

21 January 2018

Population pharmacokinetics/pharmacodynamics of docetaxel in phase II studies in patients with cancer.

1 reference

https://api.crossref.org/works/10.1177%2F1078155213480536

21 January 2018

Population pharmacokinetics of docetaxel in patients with hepatic dysfunction treated in an oncology practice

1 reference

https://api.crossref.org/works/10.1177%2F1078155213480536

21 January 2018

Pharmacokinetics of paclitaxel and three major metabolites in patients with advanced breast carcinoma refractory to anthracycline therapy treated with a 3-hour paclitaxel infusion: a European Cancer Centre (ECC) trial.

1 reference

https://api.crossref.org/works/10.1177%2F1078155213480536

21 January 2018

Population pharmacokinetics and pharmacokinetic-pharmacodynamic relationships for docetaxel

1 reference

https://api.crossref.org/works/10.1177%2F1078155213480536

21 January 2018

Prognostic factors for patients with hepatic metastases from breast cancer

1 reference

https://api.crossref.org/works/10.1177%2F1078155213480536

21 January 2018

The erythromycin breath test reflects P-glycoprotein function independently of cytochrome P450 3A activity

1 reference

https://api.crossref.org/works/10.1177%2F1078155213480536

21 January 2018

Identifiers

10.1177/1078155213480536

1 reference

Europe PubMed Central

18 September 2017

1 reference

Europe PubMed Central

18 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40247703&oldid=2144579322"